Mondésert O - Search Results

1

Quantitative Analysis of Cell Aggregation Dynamics Identifies HDAC Inhibitors as Potential Regulators of Cancer Cell Clustering.

Gava F, Pignolet J, Déjean S, Mondésert O, Morin R, Agossa J, Ducommun B, Lobjois V. Gava F, et al. Among authors: mondesert o. Cancers (Basel). 2021 Nov 21;13(22):5840. doi: 10.3390/cancers13225840. Cancers (Basel). 2021. PMID: 34830995 Free PMC article.

2

Gap junctions contribute to anchorage-independent clustering of breast cancer cells.

Gava F, Rigal L, Mondesert O, Pesce E, Ducommun B, Lobjois V. Gava F, et al. Among authors: mondesert o. BMC Cancer. 2018 Feb 27;18(1):221. doi: 10.1186/s12885-018-4148-5. BMC Cancer. 2018. PMID: 29482519 Free PMC article.

3

Mitotic arrest affects clustering of tumor cells.

Bonnet J, Rigal L, Mondesert O, Morin R, Corsaut G, Vigneau M, Ducommun B, Lobjois V. Bonnet J, et al. Among authors: mondesert o. Cell Div. 2021 Jan 29;16(1):2. doi: 10.1186/s13008-021-00070-z. Cell Div. 2021. PMID: 33514388 Free PMC article.

4

Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D.

Laurent J, Frongia C, Cazales M, Mondesert O, Ducommun B, Lobjois V. Laurent J, et al. Among authors: mondesert o. BMC Cancer. 2013 Feb 8;13:73. doi: 10.1186/1471-2407-13-73. BMC Cancer. 2013. PMID: 23394599 Free PMC article.

5

Monitoring the Activation of the DNA Damage Response Pathway in a 3D Spheroid Model.

Mondesert O, Frongia C, Clayton O, Boizeau ML, Lobjois V, Ducommun B. Mondesert O, et al. PLoS One. 2015 Jul 30;10(7):e0134411. doi: 10.1371/journal.pone.0134411. eCollection 2015. PLoS One. 2015. PMID: 26225756 Free PMC article.

6

A checkpoint-oriented cell cycle simulation model.

Bernard D, Mondesert O, Gomes A, Duthen Y, Lobjois V, Cussat-Blanc S, Ducommun B. Bernard D, et al. Among authors: mondesert o. Cell Cycle. 2019 Apr;18(8):795-808. doi: 10.1080/15384101.2019.1591125. Epub 2019 Apr 4. Cell Cycle. 2019. PMID: 30870080 Free PMC article.

7

Human CDC25B and CDC25C differ by their ability to restore a functional checkpoint response after gene replacement in fission yeast.

Mondesert O, Ducommun B, Bugler B. Mondesert O, et al. Biochem Biophys Res Commun. 2002 Jul 19;295(3):673-7. doi: 10.1016/s0006-291x(02)00739-8. Biochem Biophys Res Commun. 2002. PMID: 12099692

8

Ability of human CDC25B phosphatase splice variants to replace the function of the fission yeast Cdc25 cell cycle regulator.

Lemaire M, Mondesert O, Bugler B, Ducommun B. Lemaire M, et al. Among authors: mondesert o. FEMS Yeast Res. 2004 Dec;5(3):205-11. doi: 10.1016/j.femsyr.2004.07.003. FEMS Yeast Res. 2004. PMID: 15556082

9

CDC25B phosphorylation by p38 and MK-2.

Lemaire M, Froment C, Boutros R, Mondesert O, Nebreda AR, Monsarrat B, Ducommun B. Lemaire M, et al. Among authors: mondesert o. Cell Cycle. 2006 Aug;5(15):1649-53. doi: 10.4161/cc.5.15.3006. Epub 2006 Aug 1. Cell Cycle. 2006. PMID: 16861915

10

Inhibitors of the CDC25 phosphatases.

Prevost GP, Brezak MC, Goubin F, Mondesert O, Galcera MO, Quaranta M, Alby F, Lavergne O, Ducommun B. Prevost GP, et al. Among authors: mondesert o. Prog Cell Cycle Res. 2003;5:225-34. Prog Cell Cycle Res. 2003. PMID: 14593717 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page